Intervention

[14C]AZD4604 Oral Solution, 4 mg (NMT 37.0 kBq)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604NCT06157255 · 2024-02-16

COMPLETED

Common conditions

Asthma1

Leading sponsors

AstraZeneca1

Trial status mix

COMPLETED1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.